Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-3,400
Closed -$923K 641
2017
Q2
$923K Sell
3,400
-5,400
-61% -$1.43M 0.03% 386
2017
Q1
$2.41M Buy
8,800
+5,800
+193% +$1.64M 0.02% 628
2016
Q4
$851K Sell
3,000
-15,600
-84% -$4.62M ﹤0.01% 1370
2016
Q3
$5.82M Sell
18,600
-58,200
-76% -$17.2M 0.03% 443
2016
Q2
$18.6M Buy
76,800
+28,200
+58% +$7.43M 0.09% 197
2016
Q1
$12.7M Buy
48,600
+1,900
+4% +$502K 0.06% 257
2015
Q4
$14.3M Sell
46,700
-164,400
-78% -$47.2M 0.07% 234
2015
Q3
$61.6M Buy
211,100
+46,800
+28% +$15.5M 0.26% 64
2015
Q2
$66.4M Sell
164,300
-16,500
-9% -$6.62M 0.3% 44
2015
Q1
$76.3M Buy
180,800
+83,600
+86% +$32.9M 0.34% 34
2014
Q4
$33M Sell
97,200
-30,400
-24% -$9.83M 0.13% 119
2014
Q3
$42.2M Buy
127,600
+10,600
+9% +$3.5M 0.17% 77
2014
Q2
$36.9M Sell
117,000
-53,300
-31% -$16M 0.17% 79
2014
Q1
$52.1M Buy
170,300
+45,700
+37% +$14.5M 0.22% 58
2013
Q4
$34.8M Buy
124,600
+4,500
+4% +$1.16M 0.12% 110
2013
Q3
$28.9M Sell
120,100
-56,500
-32% -$12.6M 0.1% 159
2013
Q2
$38M Buy
+176,600
New +$37.7M 0.14% 110

Other funds holding BIIB

Timber Hill's BIIB Position: Q2 2018 in Review

Timber Hill sold out of Biogen (BIIB) in Q2 2018, closing a stake of 4,910 shares — an estimated $1.34M sold.

Timber Hill first reported a position in BIIB in Q3 2013 and held it in 10 quarters. The position peaked at $8.47M in Q3 2013. 1,097 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • Timber Hill reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • Timber Hill sold 4,910 Biogen shares in Q2 2018, an estimated $1.34M.
  • Timber Hill first reported a position in Biogen in Q3 2013 and held it in 10 quarters.
  • Timber Hill's Biogen position peaked at $8.47M in Q3 2013.
  • 1,097 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Timber Hill's 13F filing for Q2 2018, filed 9 Aug 2018.